# Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants

> **NCT05387941** · PHASE1 · COMPLETED · sponsor: **Region Skane** · enrollment: 11 (actual)

## Conditions studied

- Retinopathy of Prematurity

## Interventions

- **DRUG:** Dexamethasone Ophthalmic

## Key facts

- **NCT ID:** NCT05387941
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-14
- **Primary completion:** 2026-03-04
- **Final completion:** 2026-03-04
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05387941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05387941, "Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05387941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*